+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Novo Nordisk A/S - logo

Novo Nordisk is a global healthcare company with more than 90 years of innovation and leadership in diabetes care. Key products include diabetes care medications and devices. Novo Nordisk is also involved with hemostasis management, growth hormone therapy and hormone replacement therapy. Headquartered in Denmark, Novo Nordisk employs approximately 40,000 employees in 75 countries, and markets its products in more than 180 countries.

Hemophilia Market Report 2026 - Product Thumbnail Image

Hemophilia Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
From
From
Rnai Drug Delivery Market 2024-2028 - Product Thumbnail Image

Rnai Drug Delivery Market 2024-2028

  • Report
  • July 2024
  • 180 Pages
  • Global
From
From
Diabetes Management Devices Market 2024-2028 - Product Thumbnail Image

Diabetes Management Devices Market 2024-2028

  • Report
  • January 2024
  • 163 Pages
  • Global
From
Pen Needles Market - Global Outlook & Forecast 2022-2027 - Product Thumbnail Image

Pen Needles Market - Global Outlook & Forecast 2022-2027

  • Report
  • August 2022
  • 325 Pages
  • Global
From
From
From
RNAi Drug Delivery: Technologies and Global Markets - Product Thumbnail Image

RNAi Drug Delivery: Technologies and Global Markets

  • Report
  • August 2023
  • 141 Pages
  • Global
From
From
From
Glucagon-Like Peptide (GLP) Agonist - Pipeline Insight, 2025 - Product Thumbnail Image

Glucagon-Like Peptide (GLP) Agonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 180 Pages
  • Global
From
Glucagon-Like Peptide 1 Receptor Agonists - Pipeline Insight, 2025 - Product Thumbnail Image

Glucagon-Like Peptide 1 Receptor Agonists - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 100 Pages
  • Global
From
Loading Indicator